Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Smallpox

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sero-Epidemiologic Study of Respiratory Syncytial Virus Infection in Korea.

Journal of Korean medical science·2026

Same author

COVID-19 Vaccination Recommendations for 2025-2026 in Korea.

Infection & chemotherapy·2026

Same author

Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis.

Journal of medical virology·2025

Same author

Breaking the mould: stakeholder insights into the shift from 2 + 4 to a 6-Year continuous medical curriculum in South Korea.

BMC medical education·2025

Same author

Pneumococcal Vaccination in Korean Adults: 2025 Recommendations by the Korean Society of Infectious Diseases.

Infection & chemotherapy·2025

Same author

Recommendations for Influenza Vaccination in Immunocompromised Patients.

Infection & chemotherapy·2025

Search research articles

Related Experiment Video

Updated: Jun 14, 2026

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

COVID-19 Vaccination Strategy and Evidence in Korea.

Young Hoon Hwang¹, Wan Beom Park²

¹Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Journal of Korean Medical Science

|March 24, 2026

Summary

COVID-19 vaccination in Korea, using updated JN.1 and LP.8.1 variant vaccines, demonstrated strong effectiveness and safety. Continued surveillance and updated policies are crucial for future pandemic preparedness.

Keywords:

COVID-19 Korea SARS-CoV-2 Vaccination

More Related Videos

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Published on: August 8, 2016

Related Experiment Videos

Last Updated: Jun 14, 2026

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Distinctive Capillary Action by Micro-channels in Bone-like Templates can Enhance Recruitment of Cells for Restoration of Large Bony Defect

Published on: September 11, 2015

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System

Published on: August 8, 2016

Area of Science:

Public Health
Immunology
Epidemiology

Background:

Coronavirus disease 2019 (COVID-19) presents significant global health challenges.
Vaccination is the primary strategy for reducing severe COVID-19 outcomes and mortality.
Korea implemented a rapid COVID-19 vaccine rollout starting February 2021, contributing to lower mortality rates.

Purpose of the Study:

To analyze the evolution of COVID-19 vaccination strategies in Korea.
To evaluate the effectiveness and safety of COVID-19 vaccines, including variant-specific formulations.
To underscore the importance of ongoing surveillance and policy updates for pandemic preparedness.

Main Methods:

Review of Korean vaccination policies and vaccine administration data.
Analysis of vaccine effectiveness and safety studies conducted in Korea.
Monitoring of epidemiological trends and emerging SARS-CoV-2 variants.

Main Results:

Korea approved six COVID-19 vaccines, adapting strategies over time.
Updated vaccines targeting JN.1 lineage (2024-2025) and LP.8.1 variant (2025-2026) were introduced.
Korean studies confirmed high vaccine effectiveness and acceptable safety profiles, aligning with global findings.

Conclusions:

COVID-19 vaccines, including updated formulations, are effective and safe in the Korean population.
Sustaining robust surveillance systems is essential for monitoring vaccine performance against evolving variants.
Adaptive vaccination policies are critical for maintaining public health security against future pandemics.